Kolexia
Roulleaux Dugage Matthieu Oncologie médicale
Roulleaux Dugage Matthieu
Oncologie médicale
Gustave-Roussy
Villejuif, France
84 Activités
676 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome pulmonaire non à petites cellules Tumeurs du poumon Sarcomes Carcinome pulmonaire à petites cellules Prédisposition aux maladies Inflammation Hypertension artérielle Tumeurs de la prostate Carcinomes

Collaborateurs

Voir plus
Catteau Ludivine
Catteau Ludivine
Hôpital privé des Peupliers, Paris, France
Jamelot Mathieu
Jamelot Mathieu
Hôpital Tenon, Paris, France
Doucet Ludovic
Doucet Ludovic
Institut de cancérologie de l'Ouest, Saint-Herblain, France
Defaucheux Cecile
Defaucheux Cecile
Centre Hospitalier d'Arcachon, La Teste-de-Buch, France

Industries

Voir plus
Amgen
2 collaboration(s)
Dernière en 2020
MSD
1 collaboration(s)
Dernière en 2023
Janssen
1 collaboration(s)
Dernière en 2023
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8 T cells in patients with advanced NSCLC.
Science advances   08 novembre 2023
1450P Addition of bevacizumab to first-line chemoimmunotherapy in NSCLC with liver metastases
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting.
Journal of hematology & oncology   08 août 2023
New drugs approval: Lutetium-PSMA in metastatic castration-resistant prostate cancer.
Bulletin du cancer   12 avril 2023
Biomarkers of response to immunotherapy in early stage non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990)   17 février 2023
20P Human virome epitope-level antiviral antibody profiling identified the cytomegalovirus (CMV) as the main driver of senescent immune phenotype (SIP) in patients with advanced non-small cell lung cancer (aNSCLC)
Abstract Book of the ESMO Immuno-Oncology Congress 2022 7-9 December 2022   01 décembre 2022
Immunosenescence, inflammaging, and cancer immunotherapy efficacy.
Expert review of anticancer therapy   14 juillet 2022
Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study.
Cancers   25 mars 2022
Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review.
Frontiers in immunology   03 décembre 2021
83P Association of lung immune prognostic index (LIPI) with progression-free survival (PFS) in soft-tissue sarcoma (STS) patients treated with immunotherapy (IO) in early phase trials
ESMO Immuno-Oncology Congress 2021 08-11 December 2021   01 décembre 2021